The 'Outperform' rating maintained by RBC Capital indicates that they expect MDA to do better than the market average. The increase in the price target from C$12 to C$14 suggests that they believe the stock has potential for further growth. This could lead to increased investor interest and a potential rise in the stock price in the short term.